IMPACT FACTOR 5.118 marine drugs an Open Access Journal by MDPI Australia New Zealand Marine Biotechnology Society (ANZMBS) is affiliated with Marine Drugs IMPACT FACTOR marine drugs 5.118 an Open Access Journal by MDPI Editor-in-Chief Message from the Editor-in-Chief Prof. Orazio Taglialatela-Scafati The marine environment has become a recognized source Associate Editors for the discovery of bioactive compounds, as testified by Prof. Dr. Anake Kijjoa Prof. Dr. Vassilios Roussis the solid preclinical/clinical pipeline that currently exists Prof. Dr. Claudiu T. Supuran for marine-derived products. Marine Drugs is inviting Dr. Hitoshi Sashiwa contributions on new advances in marine natural product Prof. Dr. Marialuisa Menna Dr. Ipek Kurtboke chemistry, marine biotechnology, marine pharmacology Prof. Dr. Bill J. Baker and genomics related to the discovery of biologically and Prof. Dr. Marc Diederich therapeutically relevant marine natural products. Our goal is to share sound contributions in a timely fashion and in a manner that will be valued by the scientific community. Author Benefits Impact Factor 5.118 Q1 in “Pharmacology, Pharmacy”, Q1 in “Chemistry, Medicinal” (JCR categories) CiteScore 6.4 Q1 in “Pharmacology, Toxicology and Pharmaceutics (miscellaneous)”, Q1 in “Pharmaceutical Science”, and Q1 in “Drug Discovery” (Scopus categories) Coverage by Leading Indexing Services SCIE-Science Citation Index Expanded (Clarivate Analytics), PubMed (NLM), MEDLINE (NLM), Scopus (Elsevier), MarinLit (RSC) Thorough Peer-Review Open Access Unlimited and free access for readers No Copyright Constraints Retain copyright of your work and free use of your article Rapid Publication A first decision provided to authors approximately 11.7 days after submission; acceptance to publication is undertaken in 2.8 days (median values for papers published in this journal in the first half of 2021) Aims and Scope Marine Drugs (ISSN 1660-3397) publishes peer-reviewed research papers, short notes, and reviews reporting on the discovery, development, exploitation, and production of biologically and therapeutically active compounds from marine habitats. Identification of bioactive compounds from marine microorganisms, invertebrates, fishes, and plants Pharmacological characterization of marine compounds or their derivatives Marine natural products with activity against human, animal and plant diseases Marine natural products with insecticidal or herbicidal activities Synthesis, mutasynthesis and medicinal chemistry of marine natural products Marine proteomics, glycomics, and lipidomics related to drug discovery or bioactivity Marine drug development, including pharmaceutical formulation and clinical trials Marine chemical ecology research inspiring marine drug discovery Innovative sampling and isolation techniques targeting bioactive marine natural products Marine biotechnology and molecular biology studies Editorial Office related to drug discovery or production Marine Drugs Editorial Office Structural and biological characterization of marine [email protected] MDPI, St. Alban-Anlage 66 toxins 4052 Basel, Switzerland Biomaterials of marine origin Tel: +41 61 683 77 34 Marine-derived ingredients for cosmeceuticals, Fax: +41 61 302 89 18 www.mdpi.com nutraceuticals, marine-derived functional foods and mdpi.com/journal/marinedrugs nutritional supplements MDPI is a member of Affiliated Societies Follow Us facebook.com/MDPIOpenAccessPublishing twitter.com/MDPIOpenAccess linkedin.com/company/mdpi weibo.com/mdpicn Wechat: MDPI-China blog.mdpi.com www.mdpi.com mdpi.com/journal/marinedrugs See www.mdpi.com for a full list of offices and contact information. MDPI is a company registered in Basel, Switzerland, No. CH-270.3.014.334-3, whose registered office is at St. Alban-Anlage 66, CH-4052 Basel, Switzerland. Basel, July 2021.